🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative findings that clarify how the immune system targets harmful infections while protecting the healthy tissues.

A trio of renowned scientists—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this accolade.

Their research uncovered specialized "sentinels" within the defense system that eliminate malfunctioning defense cells capable of harming the organism.

The discoveries are now paving the way for innovative treatments for immune disorders and cancer.

These laureates will divide a prize fund worth 11m Swedish kronor.

Crucial Discoveries

"The work has been decisive for understanding how the body's defenses functions and why we do not all develop serious autoimmune diseases," stated the chair of the award panel.

This team's research explain a fundamental mystery: In what way does the immune system protect us from countless invaders while leaving our healthy cells intact?

Our immune system uses white blood cells that scan for indicators of infection, even viruses and germs it has not met before.

Such defenders utilize sensors—called recognition units—that are generated randomly in a vast number of combinations.

This gives the defense network the ability to fight a broad range of invaders, but the unpredictability of the process unavoidably creates immune cells that may target the body.

Protectors of the Body

Scientists previously knew that some of these problematic defense cells were destroyed in the immune organ—where white blood cells develop.

The latest award honors the discovery of regulatory T-cells—known as the immune system's "security guards"—which patrol the body to neutralize other defenders that attack the healthy cells.

We know that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "The discoveries have established a new field of research and spurred the development of innovative treatments, for instance for cancer and immune disorders."

Regarding malignancies, regulatory T-cells block the body from fighting the tumor, so research are focused on reducing their numbers.

In self-attack disorders, trials are testing increasing regulatory T-cells so the organism is not being harmed. A similar approach could also be useful in minimizing the chances of organ transplant failure.

Innovative Studies

Prof Shimon Sakaguchi, from a Japanese institution, performed experiments on mice that had their immune gland extracted, leading to autoimmune disease.

The researcher demonstrated that injecting defense cells from other mice could prevent the disease—implying there was a system for preventing defenders from harming the body.

Mary Brunkow, from the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in rodents and people that led to the discovery of a gene vital for how regulatory T-cells function.

"Their pioneering research has uncovered how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the healthy cells," commented a prominent biological science specialist.

"This work is a remarkable illustration of how fundamental biological research can have broad consequences for public health."